Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

Combining 18F-FDG PET/CT-based Metabolically Active Tumor Volume and Circulating Cell-free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Woff E, Kehagias P, Vandeputte C, Ameye L, Guiot T, Paesmans M, Hendlisz A, Flamen P.

J Nucl Med. 2019 Mar 8. pii: jnumed.118.222919. doi: 10.2967/jnumed.118.222919. [Epub ahead of print]

PMID:
30850494
2.

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.

Charette N, Vandeputte C, Ameye L, Bogaert CV, Krygier J, Guiot T, Deleporte A, Delaunoit T, Geboes K, Van Laethem JL, Peeters M, Demolin G, Holbrechts S, Flamen P, Paesmans M, Hendlisz A.

BMC Cancer. 2019 Feb 12;19(1):134. doi: 10.1186/s12885-019-5319-8.

3.

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.

Haltout J, Awada A, Paesmans M, Moreau M, Klastersky J, Machiels G, Ignatiadis M, Kotecki N.

Support Care Cancer. 2019 Apr;27(4):1163-1170. doi: 10.1007/s00520-018-4602-6. Epub 2019 Jan 4. Review.

PMID:
30610431
4.

Clinical outcomes of laryngopharyngeal reflux treatment: A systematic review and meta-analysis.

Lechien JR, Saussez S, Schindler A, Karkos PD, Hamdan AL, Harmegnies B, De Marrez LG, Finck C, Journe F, Paesmans M, Vaezi MF.

Laryngoscope. 2018 Dec 30. doi: 10.1002/lary.27591. [Epub ahead of print]

PMID:
30597577
5.

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber RM, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora PM, Samarzija M, Scherpereel A, Schlesser M, Sculier JP, Skrickova J, Sotto-Mayor R, Strand TE, Van Schil P, Blum TG.

BMC Cancer. 2018 Nov 20;18(1):1144. doi: 10.1186/s12885-018-5009-y.

6.

Risk factors for the development of brain metastases in patients with HER2-positive breast cancer.

Maurer C, Tulpin L, Moreau M, Dumitrescu C, de Azambuja E, Paesmans M, Nogaret JM, Piccart MJ, Awada A.

ESMO Open. 2018 Oct 24;3(6):e000440. doi: 10.1136/esmoopen-2018-000440. eCollection 2018.

7.

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NG, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher DKM, Sculier JP, Schepereel A, Subotic DR, Van Schil P, Blum TG.

Eur Respir J. 2018 Dec 20;52(6). pii: 1800610. doi: 10.1183/13993003.00610-2018. Print 2018 Dec.

PMID:
30361252
9.

Metabolic Active Tumor Volume and Total Lesion Glycolysis by 18F-FDG PET/CT Validated as Prognostic Imaging Biomarkers in Chemorefractory Metastatic Colorectal Cancer.

Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P.

J Nucl Med. 2018 Jun 29. pii: jnumed.118.210161. doi: 10.2967/jnumed.118.210161. [Epub ahead of print]

PMID:
29959212
10.

[Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation].

Cilla N, Vercruyssen M, Ameye L, Paesmans M, de Wind A, Heimann P, Meuleman N, Bron D.

Rev Med Brux. 2018 May 30. doi: 10.30637/2018.17-090. [Epub ahead of print] French.

PMID:
29869471
11.

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.

Vandeputte C, Kehagias P, El Housni H, Ameye L, Laes JF, Desmedt C, Sotiriou C, Deleporte A, Puleo F, Geboes K, Delaunoit T, Demolin G, Peeters M, D'Hondt L, Janssens J, Carrasco J, Marechal R, Galdon MG, Heimann P, Paesmans M, Flamen P, Hendlisz A.

Oncotarget. 2018 Apr 3;9(25):17756-17769. doi: 10.18632/oncotarget.24879. eCollection 2018 Apr 3.

12.

Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.

Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber RD, Campbell I, Nordenskjöld B, Gutiérez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, Crown J, Piccart-Gebhart M, Francis PA.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):316-324. doi: 10.1016/j.ijrobp.2018.01.105. Epub 2018 Feb 6.

PMID:
29534902
13.

A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.

Sculier JP, Lafitte JJ, Berghmans T, Meert AP, Scherpereel A, Roelandts M, Van Cutsem O, Colinet B, Bonduelle Y, Giner V, Paesmans M, Leclercq N, Van Houtte P.

Lung Cancer. 2018 Mar;117:32-37. doi: 10.1016/j.lungcan.2017.12.016. Epub 2018 Jan 31.

PMID:
29496253
14.

Response.

Lambertini M, Ameye L, Paesmans M, Peccatori FA, Azim HA Jr.

J Natl Cancer Inst. 2018 Aug 1;110(8):919-920. doi: 10.1093/jnci/djx292. No abstract available.

PMID:
29329404
15.

Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?

Albisinni S, Aoun F, Noel A, El Rassy E, Lemort M, Paesmans M, van Velthoven R, Roumeguère T, Peltier A.

Prog Urol. 2018 Jan;28(1):18-24. doi: 10.1016/j.purol.2017.10.001. Epub 2017 Dec 6.

PMID:
29203158
16.

Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studies.

Cappelle SI, Ramon I, Dekelver C, Rozenberg S, Baleanu F, Karmali R, Rubinstein M, Tondeur M, Moreau M, Paesmans M, Bergmann P, Body JJ.

Maturitas. 2017 Dec;106:1-7. doi: 10.1016/j.maturitas.2017.08.010. Epub 2017 Aug 24.

PMID:
29150162
17.

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial.

Buisseret L, Pommey S, Allard B, Garaud S, Bergeron M, Cousineau I, Ameye L, Bareche Y, Paesmans M, Crown JPA, Di Leo A, Loi S, Piccart-Gebhart M, Willard-Gallo K, Sotiriou C, Stagg J.

Ann Oncol. 2018 Apr 1;29(4):1056-1062. doi: 10.1093/annonc/mdx730.

PMID:
29145561
18.

Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status.

Lambertini M, Kroman N, Ameye L, Cordoba O, Pinto A, Benedetti G, Jensen MB, Gelber S, Del Grande M, Ignatiadis M, de Azambuja E, Paesmans M, Peccatori FA, Azim HA Jr.

J Natl Cancer Inst. 2018 Apr 1;110(4):426-429. doi: 10.1093/jnci/djx206.

PMID:
29087485
19.

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.

Berghmans T, Scherpereel A, Meert AP, Giner V, Lecomte J, Lafitte JJ, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party (ELCWP).

Front Oncol. 2017 Sep 19;7:217. doi: 10.3389/fonc.2017.00217. eCollection 2017.

20.

Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies.

Lebrun F, Klastersky J, Levacq D, Wissam Y, Paesmans M.

Support Care Cancer. 2017 Jul;25(7):2313-2319. doi: 10.1007/s00520-017-3672-1. Epub 2017 Apr 7. Review.

PMID:
28386789
21.

The Prognostic Role of Androgen Receptor in Patients with Early-Stage Breast Cancer: A Meta-analysis of Clinical and Gene Expression Data.

Bozovic-Spasojevic I, Zardavas D, Brohée S, Ameye L, Fumagalli D, Ades F, de Azambuja E, Bareche Y, Piccart M, Paesmans M, Sotiriou C.

Clin Cancer Res. 2017 Jun 1;23(11):2702-2712. doi: 10.1158/1078-0432.CCR-16-0979. Epub 2016 Nov 9.

22.

First 200 consecutive transumbilical single-incision laparoscopic TEPs.

Dapri G, Gerard L, Paesmans M, Cadière GB, Saussez S.

Hernia. 2017 Feb;21(1):29-35. doi: 10.1007/s10029-016-1564-9. Epub 2016 Dec 23.

PMID:
28012031
23.

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU.

Destrebecq V, Lieveke A, Berghmans T, Paesmans M, Sculier JP, Meert AP.

Front Med (Lausanne). 2016 Oct 31;3:50. eCollection 2016.

24.

Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.

Kourie HR, Ameye L, Paesmans M, Bron D.

Ann Hematol. 2016 Dec;95(12):2105-2106. Epub 2016 Sep 29. No abstract available.

PMID:
27686082
25.

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

Lambertini M, Pinto AC, Ameye L, Jongen L, Del Mastro L, Puglisi F, Poggio F, Bonotto M, Floris G, Van Asten K, Wildiers H, Neven P, de Azambuja E, Paesmans M, Azim HA Jr.

Br J Cancer. 2016 Dec 6;115(12):1471-1478. doi: 10.1038/bjc.2016.359. Epub 2016 Nov 1.

26.

Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.

Farinella E, Safar A, Nasser HA, Bouazza F, Liberale G, Paesmans M, Marechal R, Van Laethem JL, Hendlisz A, VanHoutte P, El Nakadi I.

J Surg Oncol. 2016 Dec;114(7):833-837. doi: 10.1002/jso.24429. Epub 2016 Oct 25.

PMID:
27778349
27.

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study.

Berghmans T, Lafitte JJ, Scherpereel A, Ameye L, Paesmans M, Meert AP, Colinet B, Tulippe C, Willems L, Leclercq N, Sculier JP; European Lung Cancer Working Party.

ERJ Open Res. 2015 Oct 19;1(2). pii: 00029-2015. eCollection 2015 Oct.

28.

Biomarkers for adverse events associated with immune checkpoint inhibitors.

Kourie HR, Paesmans M, Klastersky J.

Biomark Med. 2016 Oct;10(10):1029-1031. Epub 2016 Sep 14. No abstract available.

PMID:
27626646
29.

Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.

Gil T, Sideris S, Aoun F, van Velthoven R, Sirtaine N, Paesmans M, Ameye L, Awada A, Devriendt D, Peltier A.

Mol Clin Oncol. 2016 Sep;5(3):258-264. Epub 2016 Jul 14.

30.

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D.

PLoS One. 2016 Aug 1;11(8):e0159734. doi: 10.1371/journal.pone.0159734. eCollection 2016.

31.

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, D'Hondt V, De Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart M, Awada A.

PLoS One. 2016 Jul 25;11(7):e0154009. doi: 10.1371/journal.pone.0154009. eCollection 2016.

32.

Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis.

Kourie HR, Ameye L, Paesmans M, Bron D.

Br J Haematol. 2017 Dec;179(5):846-848. doi: 10.1111/bjh.14259. Epub 2016 Jul 19. No abstract available.

PMID:
27434541
33.

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Phillips RS, Sung L, Ammann RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA.

Br J Cancer. 2016 Jun 14;114(12):e17. doi: 10.1038/bjc.2016.137. Epub 2016 May 26. No abstract available.

34.

Results of the Belgian expanded access program of eribulin in the treatment of metastatic breast cancer closely mirror those of the pivotal phase III trial.

Aftimos P, Polastro L, Ameye L, Jungels C, Vakili J, Paesmans M, van den Eerenbeemt J, Buttice A, Gombos A, de Valeriola D, Gil T, Piccart-Gebhart M, Awada A.

Eur J Cancer. 2016 Jun;60:117-24. doi: 10.1016/j.ejca.2016.03.010. Epub 2016 Apr 20.

PMID:
27107326
35.

[The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].

Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP.

Rev Mal Respir. 2016 Nov;33(9):759-765. doi: 10.1016/j.rmr.2016.02.004. Epub 2016 Mar 24. French.

PMID:
27017064
36.

Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis.

Phillips RS, Sung L, Ammann RA, Riley RD, Castagnola E, Haeusler GM, Klaassen R, Tissing WJ, Lehrnbecher T, Chisholm J, Hakim H, Ranasinghe N, Paesmans M, Hann IM, Stewart LA; PICNICC Collaboration.

Br J Cancer. 2016 Mar 15;114(6):623-30. doi: 10.1038/bjc.2016.28. Epub 2016 Mar 8. Erratum in: Br J Cancer. 2016 Jun 14;114(12):e17.

37.

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Kourie HR, Ameye L, Paesmans M, Bron D.

Clin Lymphoma Myeloma Leuk. 2016 May;16(5):264-8. doi: 10.1016/j.clml.2016.01.009. Epub 2016 Feb 6.

PMID:
26935576
38.

The current use and attitudes towards tumor genome sequencing in breast cancer.

Gingras I, Sonnenblick A, de Azambuja E, Paesmans M, Delaloge S, Aftimos P, Piccart MJ, Sotiriou C, Ignatiadis M, Azim HA Jr.

Sci Rep. 2016 Mar 2;6:22517. doi: 10.1038/srep22517.

39.

[Difficulties and limitations in conducting translational research in thoracic oncology. A practical example].

Meert AP, Ameye L, Leclercq N, Paesmans M, Remmelink M, Sculier JP, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):594-9. doi: 10.1016/j.rmr.2015.10.744. Epub 2016 Jan 6. French.

PMID:
26777111
40.

Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.

Peltier A, Aoun F, Albisinni S, Marcelis Q, Ledinh D, Paesmans M, Lemort M, van Velthoven R.

Scand J Urol. 2016 Jun;50(3):144-8. doi: 10.3109/21681805.2015.1118408. Epub 2016 Jan 12.

PMID:
26754860
41.

Opioid-free anesthesia: what about patient comfort? A prospective, randomized, controlled trial.

Hontoir S, Saxena S, Gatto P, Khalife M, Ben Aziz AM, Paesmans M, Sosnowski M.

Acta Anaesthesiol Belg. 2016;67(4):183-190.

PMID:
29873988
42.

Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.

Antoine C, Ameye L, Paesmans M, de Azambuja E, Rozenberg S.

Maturitas. 2016 Feb;84:81-8. doi: 10.1016/j.maturitas.2015.11.010. Epub 2015 Nov 25.

PMID:
26654400
43.

[Implementation of an oncological care program in a multidisciplinary clinic].

Sculier JP, Leclercq N, Meert AP, Paesmans M, Berghmans T.

Rev Mal Respir. 2016 Sep;33(7):600-6. doi: 10.1016/j.rmr.2015.10.741. Epub 2015 Nov 21. French.

PMID:
26611198
44.

Should the treatment of advanced lepidic adenocarcinoma be adapted to the pathological subtype?

Paesmans M.

Eur Respir J. 2015 Nov;46(5):1259-61. doi: 10.1183/13993003.01563-2015. No abstract available.

45.

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.

Hendlisz A, Deleporte A, Delaunoit T, Maréchal R, Peeters M, Holbrechts S, Van den Eynde M, Houbiers G, Filleul B, Van Laethem JL, Ceyssens S, Barbuto AM, Lhommel R, Demolin G, Garcia C, El Mansy H, Ameye L, Moreau M, Guiot T, Paesmans M, Piccart M, Flamen P.

PLoS One. 2015 Sep 30;10(9):e0138341. doi: 10.1371/journal.pone.0138341. eCollection 2015.

46.

Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.

Paesmans M, Garcia C, Wong CY, Patz EF Jr, Komaki R, Eschmann S, Govindan R, Vansteenkiste J, Meert AP, de Jong WK, Altorki NK, Higashi K, Van Baardwijk A, Borst GR, Ameye L, Lafitte JJ, Berghmans T, Flamen P, Rami-Porta R, Sculier JP.

Eur Respir J. 2015 Dec;46(6):1751-61. doi: 10.1183/13993003.00099-2015. Epub 2015 Sep 24.

47.

Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.

de Azambuja E, Ameye L, Diaz M, Vandenbossche S, Aftimos P, Bejarano Hernández S, Shih-Li C, Delhaye F, Focan C, Cornez N, Vindevoghel A, Beauduin M, Lemort M, Paesmans M, Suter T, Piccart-Gebhart M.

Eur J Cancer. 2015 Nov;51(17):2517-24. doi: 10.1016/j.ejca.2015.08.011. Epub 2015 Aug 27.

PMID:
26321502
48.

Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, El Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Van den Eynde M, Maréchal R, Borbath I, Dresse D, Houbiers G, Fried M, Awada A, Piccart M, Van Laethem JL, Flamen P.

BMC Cancer. 2015 Mar 25;15:173. doi: 10.1186/s12885-015-1181-5. No abstract available.

49.

Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).

Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly JP; EORTC Infectious Diseases Group.

Clin Infect Dis. 2015 Aug 1;61(3):324-31. doi: 10.1093/cid/civ293. Epub 2015 Apr 13. Erratum in: Clin Infect Dis. 2015 Nov 15;61(10):1635. Donnelly, Peter J [corrected to Donnelly, J Peter].

PMID:
25870323
50.

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.

Hendlisz A, Deleporte A, Vandeputte C, Charette N, Paesmans M, Guiot T, Garcia C, Flamen P.

BMJ Open. 2015 Mar 9;5(3):e007189. doi: 10.1136/bmjopen-2014-007189.

Supplemental Content

Loading ...
Support Center